MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September
LYON, France–(BUSINESS WIRE)–$MAAT—MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced that Hervé Affagard, CEO and co-founder of MaaT Pharma, and Siân Crouzet, CFO of MaaT Pharma, will participate in three … [Read more…]
